| Product Code: ETC13178744 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Needle Biopsy Market was valued at USD 0.63 Billion in 2024 and is expected to reach USD 0.9 Billion by 2031, growing at a compound annual growth rate of 5.50% during the forecast period (2025-2031).
The Global Needle Biopsy Market is a rapidly expanding sector driven by the increasing prevalence of cancer and the growing demand for minimally invasive diagnostic procedures. Needle biopsy procedures, which involve the extraction of tissue samples using a hollow needle, are preferred over traditional surgical biopsies due to their lower risk, shorter recovery times, and cost-effectiveness. Technological advancements such as the development of imaging-guided biopsy techniques have further boosted market growth by improving accuracy and reducing complications. Key players in the market include Becton, Dickinson and Company, Boston Scientific Corporation, Medtronic plc, and Olympus Corporation. With a rising emphasis on early detection and personalized medicine, the Global Needle Biopsy Market is expected to continue its upward trajectory in the coming years, providing opportunities for innovation and market expansion.
The Global Needle Biopsy Market is witnessing significant growth due to the rising prevalence of cancer globally and the increasing demand for minimally invasive diagnostic procedures. Technological advancements in biopsy needles, such as the development of vacuum-assisted biopsy systems and the integration of imaging guidance technologies, are driving market growth. Additionally, the growing adoption of liquid biopsy techniques for cancer diagnosis presents a lucrative opportunity for market expansion. The market is also benefiting from the increasing emphasis on early detection and personalized medicine in oncology. Mergers and acquisitions, partnerships, and collaborations among key players in the industry are further fueling market growth. With the increasing focus on precision medicine and the need for accurate cancer diagnosis, the Global Needle Biopsy Market is poised for continued growth and innovation.
The Global Needle Biopsy Market faces several challenges, including limited awareness among patients and healthcare professionals about the benefits of needle biopsy compared to traditional surgical biopsies. Additionally, there are concerns about the accuracy and reliability of needle biopsy results, leading to potential misdiagnosis and subsequent inappropriate treatment decisions. Technological limitations in certain healthcare settings, such as lack of access to advanced imaging equipment or trained specialists to perform needle biopsies, also pose significant challenges. Furthermore, regulatory hurdles and reimbursement issues related to needle biopsy procedures can hinder market growth. Addressing these challenges will require increased education and training efforts, technological advancements, and improved healthcare infrastructure in underserved regions.
The Global Needle Biopsy Market is being driven by several key factors, including the rising prevalence of cancer and other chronic diseases, increasing demand for minimally invasive diagnostic procedures, advancements in imaging technologies facilitating accurate biopsies, and growing awareness about the benefits of early cancer detection. Additionally, the shift towards personalized medicine and targeted therapies is driving the need for accurate biopsy samples for molecular testing. Moreover, the expanding geriatric population, technological advancements in biopsy devices, and the growing adoption of needle biopsy procedures by healthcare providers are also contributing to the market`s growth. Overall, these factors are expected to continue driving the Global Needle Biopsy Market in the coming years.
Government policies related to the Global Needle Biopsy Market vary by country but generally focus on regulating the safety, efficacy, and quality of needle biopsy procedures and devices. Regulatory agencies like the FDA in the United States, the European Medicines Agency in the EU, and the National Medical Products Administration in China oversee the approval and monitoring of needle biopsy products to ensure they meet established standards. These agencies set guidelines for clinical trials, product labeling, and post-market surveillance to protect patient safety and ensure the reliability of biopsy results. Additionally, reimbursement policies from government healthcare systems may influence the adoption and utilization of needle biopsy procedures, with some countries providing financial incentives or coverage for these diagnostic tests. Overall, government policies play a crucial role in shaping the regulatory environment and market dynamics for needle biopsy products globally.
The Global Needle Biopsy Market is expected to experience significant growth in the coming years, driven by increasing prevalence of cancer, technological advancements in biopsy procedures, and rising demand for minimally invasive diagnostic techniques. The market is likely to witness a surge in adoption of needle biopsy procedures due to their accuracy, safety, and cost-effectiveness compared to traditional surgical biopsies. Additionally, the growing geriatric population and expanding healthcare infrastructure in developing regions will further propel market growth. However, challenges such as reimbursement issues and lack of skilled professionals may hinder the market expansion to some extent. Overall, the Global Needle Biopsy Market is poised for steady growth, with opportunities for innovation and market penetration in emerging economies.
In the Global Needle Biopsy Market, Asia-Pacific is expected to witness significant growth due to increasing prevalence of cancer, growing healthcare infrastructure, and rising awareness about early diagnosis. North America is likely to dominate the market, driven by the presence of established healthcare facilities, advanced medical technologies, and favorable reimbursement policies. Europe is also projected to hold a substantial market share, owing to the high adoption rate of minimally invasive procedures and supportive government initiatives. The Middle East and Africa region is anticipated to show steady growth as healthcare investments increase and awareness about the benefits of needle biopsy expands. Latin America is poised for moderate growth due to improving healthcare access and rising incidences of cancer, driving the demand for needle biopsy procedures.
Global Needle Biopsy Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Needle Biopsy Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Needle Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 Global Needle Biopsy Market - Industry Life Cycle |
3.4 Global Needle Biopsy Market - Porter's Five Forces |
3.5 Global Needle Biopsy Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Needle Biopsy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Needle Biopsy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Needle Biopsy Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Global Needle Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Needle Biopsy Market Trends |
6 Global Needle Biopsy Market, 2021 - 2031 |
6.1 Global Needle Biopsy Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Needle Biopsy Market, Revenues & Volume, By Fine-needle Aspiration Biopsy, 2021 - 2031 |
6.1.3 Global Needle Biopsy Market, Revenues & Volume, By Core Needle Biopsy, 2021 - 2031 |
6.2 Global Needle Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Needle Biopsy Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.2.3 Global Needle Biopsy Market, Revenues & Volume, By Thyroid Cancer, 2021 - 2031 |
6.2.4 Global Needle Biopsy Market, Revenues & Volume, By Prostate Cancer, 2021 - 2031 |
6.2.5 Global Needle Biopsy Market, Revenues & Volume, By Transperineal, 2021 - 2031 |
6.2.6 Global Needle Biopsy Market, Revenues & Volume, By Transcrectal, 2021 - 2031 |
6.2.7 Global Needle Biopsy Market, Revenues & Volume, By Liver Cancer, 2021 - 2031 |
6.2.8 Global Needle Biopsy Market, Revenues & Volume, By Other, 2021 - 2031 |
6.3 Global Needle Biopsy Market, Revenues & Volume, By End user, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Needle Biopsy Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.3.3 Global Needle Biopsy Market, Revenues & Volume, By Diagnostics & Imaging Centers, 2021 - 2031 |
6.3.4 Global Needle Biopsy Market, Revenues & Volume, By Research Laboratories & Academic Institutes, 2021 - 2031 |
6.3.5 Global Needle Biopsy Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Needle Biopsy Market, Overview & Analysis |
7.1 North America Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
7.2 North America Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Needle Biopsy Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Needle Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Needle Biopsy Market, Revenues & Volume, By End user, 2021 - 2031 |
8 Latin America (LATAM) Needle Biopsy Market, Overview & Analysis |
8.1 Latin America (LATAM) Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Needle Biopsy Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Needle Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Needle Biopsy Market, Revenues & Volume, By End user, 2021 - 2031 |
9 Asia Needle Biopsy Market, Overview & Analysis |
9.1 Asia Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Needle Biopsy Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Needle Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Needle Biopsy Market, Revenues & Volume, By End user, 2021 - 2031 |
10 Africa Needle Biopsy Market, Overview & Analysis |
10.1 Africa Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Needle Biopsy Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Needle Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Needle Biopsy Market, Revenues & Volume, By End user, 2021 - 2031 |
11 Europe Needle Biopsy Market, Overview & Analysis |
11.1 Europe Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Needle Biopsy Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Needle Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Needle Biopsy Market, Revenues & Volume, By End user, 2021 - 2031 |
12 Middle East Needle Biopsy Market, Overview & Analysis |
12.1 Middle East Needle Biopsy Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Needle Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Needle Biopsy Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Needle Biopsy Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Needle Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Needle Biopsy Market, Revenues & Volume, By End user, 2021 - 2031 |
13 Global Needle Biopsy Market Key Performance Indicators |
14 Global Needle Biopsy Market - Export/Import By Countries Assessment |
15 Global Needle Biopsy Market - Opportunity Assessment |
15.1 Global Needle Biopsy Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Needle Biopsy Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Needle Biopsy Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Needle Biopsy Market Opportunity Assessment, By End user, 2021 & 2031F |
16 Global Needle Biopsy Market - Competitive Landscape |
16.1 Global Needle Biopsy Market Revenue Share, By Companies, 2024 |
16.2 Global Needle Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |